-
-
-
-
-
-
-
Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan
-
-
-
-
-
-
-
Intersect ENT to Report Fourth Quarter and Full Year 2020 Financial Results
-
-
-
-
-
-
-
Intersect ENT (XENT) PT Raised to $19.50 at SVB Leerink, Following Earnings
-
-
-
-
-
-
-
Intersect ENT to Report First Quarter 2020 Financial Results
-
-
-
-
-
-
-
Intersect ENT (XENT) Misses Q3 EPS by 2c, Maintains Guidance
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AT&T, Care.com, Apple, and Intersect and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Intersect ENT Reports Fourth Quarter and Full Year 2018 Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

